BR9507199A - Formas de dose sólidas contendo bismuto - Google Patents

Formas de dose sólidas contendo bismuto

Info

Publication number
BR9507199A
BR9507199A BR9507199A BR9507199A BR9507199A BR 9507199 A BR9507199 A BR 9507199A BR 9507199 A BR9507199 A BR 9507199A BR 9507199 A BR9507199 A BR 9507199A BR 9507199 A BR9507199 A BR 9507199A
Authority
BR
Brazil
Prior art keywords
forms containing
dose forms
containing bismuth
solid dose
solid
Prior art date
Application number
BR9507199A
Other languages
English (en)
Inventor
Francis Bernard Chapura
Daniel Louis Barone
Michael Gerard Colacino
Original Assignee
Procter & Gamble Cellulose
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble Cellulose filed Critical Procter & Gamble Cellulose
Publication of BR9507199A publication Critical patent/BR9507199A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR9507199A 1994-03-24 1995-02-27 Formas de dose sólidas contendo bismuto BR9507199A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21752494A 1994-03-24 1994-03-24
PCT/US1995/002385 WO1995025521A1 (en) 1994-03-24 1995-02-27 Solid dose forms containing bismuth

Publications (1)

Publication Number Publication Date
BR9507199A true BR9507199A (pt) 1997-09-09

Family

ID=22811434

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9507199A BR9507199A (pt) 1994-03-24 1995-02-27 Formas de dose sólidas contendo bismuto

Country Status (5)

Country Link
US (1) US6610673B1 (pt)
BR (1) BR9507199A (pt)
CA (1) CA2184361C (pt)
PE (1) PE46195A1 (pt)
WO (1) WO1995025521A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5702729A (en) * 1995-12-07 1997-12-30 The Procter & Gamble Company Methods for the prevention and treatment of gastrointestinal disorders caused or mediated by algae or cyanobacteria
SE507682C2 (sv) * 1996-03-29 1998-07-06 Marcin Krotkiewski Farmaceutisk beredning för behandling av gastrit, refluxesofagit, duodenit, dyspepsi och magsårssjukdom innehållande en blandning av ammoniumvismutcitrat och ett alginat
US6099865A (en) * 1998-07-08 2000-08-08 Fmc Corporation Croscarmellose taste masking
WO2014135965A1 (en) * 2013-03-07 2014-09-12 Capsugel Belgium Nv Bismuth liquid filled hard capsules

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4588589A (en) * 1983-10-13 1986-05-13 Richardson-Vicks Inc. Antidiarrheal compositions and use thereof
US4786502A (en) * 1986-10-06 1988-11-22 The Procter & Gamble Company Palatable solid pharmaceutical compositions
US4999200A (en) * 1987-12-09 1991-03-12 Marion Laboratories Psyllium tablet composition, method of manufacture and method of use
US4940695A (en) * 1987-12-10 1990-07-10 The Procter & Gamble Company Bismuth-containing pharmaceutical compositions
US5192752A (en) * 1991-01-14 1993-03-09 The Procter & Gamble Company Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate
JPH06506682A (ja) * 1991-04-04 1994-07-28 ザ、プロクター、エンド、ギャンブル、カンパニー 上部胃腸管症状を治療するための内服医薬組成物
EP0578732B1 (en) * 1991-04-04 1996-06-19 The Procter & Gamble Company Chewable antacid compositions
US5244670A (en) * 1991-04-04 1993-09-14 The Procter & Gamble Company Ingestible pharmaceutical compositions for treating upper gastrointestinal tract distress
ATE157250T1 (de) * 1991-11-22 1997-09-15 Procter & Gamble Wismutsubsalicylat in form einer einheitsdosis
CA2132012C (en) * 1992-03-25 2003-04-22 John W. Shell Alkyl-substituted cellulose-based sustained-release oral drug dosage forms
US5399356A (en) * 1994-03-24 1995-03-21 The Procter & Gamble Company Process for making solid dose forms containing bismuth

Also Published As

Publication number Publication date
MX9604298A (es) 1997-12-31
WO1995025521A1 (en) 1995-09-28
PE46195A1 (es) 1995-12-22
CA2184361C (en) 2000-12-05
CA2184361A1 (en) 1995-09-28
US6610673B1 (en) 2003-08-26

Similar Documents

Publication Publication Date Title
NO972409D0 (no) Doseindikeringsanordning
DK0777671T3 (da) Spiro-azabicykliske forbindelser
FI963201A (fi) Loisten häätöön käytettäviä aineita
LV11684A (lv) Pesticidi
DE69333845D1 (de) Axiallüfter
BR9709956A (pt) Formas de dosagem oral sólidas de valsartan
NO972549D0 (no) Absorberende material
TR199501568A2 (tr) Tasikinin öncüleri.
DE59506528D1 (de) Schädlingsbekämpfungsmittel
FI955587A0 (fi) Kemialliset yhdisteet
MX201287B (es) Material absorbente.
NO973459D0 (no) Vismut-forbindelser
DE69414662D1 (de) Begasungsmittel
BR9507909A (pt) Formas de dosagem de rápida dissolução
DE69513415D1 (de) Verbesserte zitze
FI970151A (fi) Viruksenvastaisesti vaikuttavia difluoristatoniyhdisteitä
FI945907A0 (fi) Kemiallisia yhdisteitä
BR9507199A (pt) Formas de dose sólidas contendo bismuto
BR9509740A (pt) Compostos 18-nor-vitamina d
BR9507138A (pt) Processo para fazer formas de dose sólidas contendo bismuto
DE59510194D1 (de) Dose
BR9502788A (pt) Comppsição inseticida
FI965230A (fi) Bakteerinvastaisia aineita
FI962007A0 (fi) Yhteensovitettavia aineita
KR950022649U (ko) 약탕기

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FB36 Technical and formal requirements: requirement - article 36 of industrial property law
HJEG Technical examination (opinion): technical examination (opinion) related to article 229 of industrial property law
FF Decision: intention to grant
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 19A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2258 DE 15-04-2014 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.